Related references
Note: Only part of the references are listed.A cost-effectiveness analysis of real-world treatment for elderly patients with multiple myeloma using a full disease model
Hedwig M. Blommestein et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma
Luciano J. Costa et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century
Dianne Pulte et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
Antonio Palumbo et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era
Li Tao et al.
BLOOD (2014)
Combination of International Scoring System 3, High Lactate Dehydrogenase, and t(4;14) and/or del(17p) Identifies Patients With Multiple Myeloma (MM) Treated With Front-Line Autologous Stem-Cell Transplantation at High Risk of Early MM Progression-Related Death
Philippe Moreau et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
S. K. Kumar et al.
LEUKEMIA (2014)
Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma
C. J. Heuck et al.
LEUKEMIA (2014)
Recent improvement in survival of patients with multiple myeloma: variation by ethnicity
Dianne Pulte et al.
LEUKEMIA & LYMPHOMA (2014)
Trends in Utilization and Outcomes of Autologous Transplantation as Early Therapy for Multiple Myeloma
Luciano J. Costa et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach
Angela Baker et al.
BLOOD (2013)
Marital Status and Survival in Patients With Cancer
Ayal A. Aizer et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project
H. Avet-Loiseau et al.
LEUKEMIA (2013)
Health Care Costs and Resource Utilization, Including Patient Burden, Associated With Novel-Agent-Based Treatment Versus Other Therapies for Multiple Myeloma: Findings Using Real-World Claims Data
April Teitelbaum et al.
ONCOLOGIST (2013)
Comparative Effectiveness Research in Oncology: An Overview
Gary H. Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Estimated Deaths Attributable to Social Factors in the United States
Sandro Galea et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2011)
Effects of Individual-Level Socioeconomic Factors on Racial Disparities in Cancer Treatment and Survival
Xianglin L. Du et al.
CANCER (2011)
Multiple myeloma and the road to personalised medicine
Stephen J. Russell et al.
LANCET ONCOLOGY (2011)
Racial disparities in incidence and outcome in multiple myeloma: a population-based study
Adam J. Waxman et al.
BLOOD (2010)
Improved survival among younger but not among older patients with Multiple Myeloma in the Netherlands, a population-based study since 1989
Michael Schaapveld et al.
EUROPEAN JOURNAL OF CANCER (2010)
Bortezomib Plus Dexamethasone Is Superior to Vincristine Plus Doxorubicin Plus Dexamethasone As Induction Treatment Prior to Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: Results of the IFM 2005-01 Phase III Trial
Jean-Luc Harousseau et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2010)
Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis
O. Landgren et al.
LEUKEMIA (2009)
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma
Jesus F. San Miguel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Recent major improvement in long-term survival of younger patients with multiple myeloma
Hermann Brenner et al.
BLOOD (2008)
Meta-analysis of racial disparities in survival in association with socioeconomic status among men and women with colon cancer
Xianglin L. Du et al.
CANCER (2007)
Patterns of survival in multiple myeloma:: A population-based study of patients diagnosed in Sweden from 1973 to 2003
Sigurdur Yngvi Kristinsson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Share Paper
